Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) EPS (Basic) (2016 - 2025)

Standard Biotools (LAB) has disclosed EPS (Basic) for 16 consecutive years, with -$0.01 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 87.5% to -$0.01 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.21 through Dec 2025, up 57.14% year-over-year, with the annual reading at -$0.2 for FY2025, 61.54% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.01 at Standard Biotools, up from -$0.08 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.01 in Q4 2025, with the low at -$0.99 in Q1 2022.
  • Average EPS (Basic) over 5 years is -$0.25, with a median of -$0.22 recorded in 2023.
  • The sharpest move saw EPS (Basic) plummeted 296.0% in 2022, then surged 87.5% in 2025.
  • Over 5 years, EPS (Basic) stood at -$0.18 in 2021, then crashed by 44.44% to -$0.26 in 2022, then rose by 3.85% to -$0.25 in 2023, then skyrocketed by 68.0% to -$0.08 in 2024, then soared by 87.5% to -$0.01 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.01, -$0.08, and -$0.05 for Q4 2025, Q3 2025, and Q2 2025 respectively.